Pontifax Venture Capital

https://www.pontifax.com

Pontifax was founded in 2004 and is a healthcare-dedicated venture capital firm with $1.2 billion under management. Pontifax focuses on groundbreaking innovations in life sciences. It seeks transformative, cutting-edge life sciences technologies at all development stages. Its portfolio comprises of about 100 companies that develop breakthrough solutions to substantial unmet needs. *

	Start	2021-12-07 existent
	Group	Pontifax (Group)
	Industry	venture capital
	Industry 2	LIFE SCIENCES
	Person	Hammer, Ohad (Pontifax 201711 Partner)

	City	n. a.
		Address record changed: 2023-04-05

Basic data	Employees	n. a.
	Currency	USD
	Annual sales	1,200,000,000 (capital under management (2023) 2023-04-04)

		* Document for »About Section«: Adcendo ApS. (4/4/23). "Press Release: Adcendo ApS Announces Extension of Series A Financing to 82M EUR to Ensure Broad Development of its First-in-class ADC Pipeline". Copenhagen.

		Record changed: 2023-04-05

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x200px

More documents for Pontifax (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)